semaglutide essence trial PDF) 2.4 mg in Participants With Metabolic Dysfunction‐Associated Steatohepatitis: Baseline Characteristics and Design of the Phase 3 essence study semaglutide Phase 3

GLP-1 agonists are a class of prescription medications that were developed to help people with type 2 diabetes manage blood sugar levels

Generic health apps weren't designed for the unique needs of GLP-1 medications

Reduced Plateaus in Weight Loss When people lose weight, they sometimes hit a plateaua period where weight loss slows down or stops even though they are still following their plan

Based on the current biopharmaceutical landscape in early 2026, Viking Therapeutics (VKTX) remains one of the most attractive bolt-on acquisition targets for large-cap pharma companies looking to secure a foothold in the $100 billion obesity market

Breastfeeding and risk of overweight in childhood and beyond: a systematic review with emphasis on sibling-pair and intervention studies

A new non-traditional antibacterial drug fluorothiazinoneclinical research in patients with complicated urinary tract infections